AbbVie Biotech Ventures

company

About

AbbVie Biotech Ventures, an Illinois-based company, makes investments in emerging biotech and pharmaceutical companies.

  • 10001 - max

Details

Industries
Biotechnology,Financial Services,Venture Capital
Founded date
Jan 1, 2013
Number Of Employee
10001 - max
Operating Status
Active
Investor Type
CVC,Venture Capital

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.

Investments

Number of Investments
Number of Lead Investments
11
3
AbbVie Biotech Ventures has made 11 investments. Their most recent investment was on Nov 15, 2022, when Jnana Therapeutics raised $107M.
Date Company Name
Round Money Raised Industry Lead Investor
Series C $107M Biotechnology
Series B $50M Biotechnology
Series B $12M Biotechnology
Series B $47M Biotechnology
Jan 11, 2020 PACT Pharma
Series C $75M Biotechnology